Search results
Eli Lilly (LLY) Q1 Earnings Top, Sales Miss, 2024 View Raised
Zacks· 3 days agoEli Lilly (LLY) beats first-quarter estimates for earnings but misses the same for sales. It raises...
Lilly hikes revenue forecast by $2B as GLP-1 drug sales climb
BioPharma Dive via Yahoo Finance· 3 days agoLilly noted that its so-called “incretin medicines” — a group that also includes its earlier...
Why Is Eli Lilly Stock Trading Higher On Tuesday? - Eli Lilly and Co (NYSE:LLY)
Benzinga· 2 days agoThe volume increase was primarily driven by growth from Mounjaro, Zepbound, Verzenio, and Jardiance,...
Decoding Eli Lilly and Co (LLY): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 2 days agoHowever, this was partially offset by decreased sales of Trulicity. The company's net income and...
Eli Lilly assures investors it can overcome the high-quality problem of too much demand
CNBC· 2 days agoEli Lilly 's raised guidance stole the show Tuesday, offsetting mixed first-quarter results and propelling shares higher by nearly 6%. The numbers leave little doubt that the long-term Eli Lilly ...
Eli Lilly (LLY) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 2 days agoU.S. revenue increased 28% in Q1 driven by growth of Mounjaro, Zepbound, and Verzenio. Unprecedented demand for our incretin medicines led to wholesaler...
ETFs to Buy as Eli Lilly Beats Q1 Earnings, Lifts Outlook
Zacks via Yahoo Finance· 1 day agoEli Lilly and Company (LLY) raised its outlook for 2024 on rapidly climbing sales of the new obesity...
Why Eli Lilly's earnings are no sure thing for traders despite obesity drug momentum
CNBC· 3 days agoEli Lilly appears to be making as much of its popular obesity and diabetes medicines as it can, but...
Denmark to restrict Ozempic, other GLP-1 drugs, to treat type 2 diabetes
Reuters via Yahoo News· 2 days agoDenmark will start putting patients suffering from type 2 diabetes on cheaper drugs before...
Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues
Associated Press via Yahoo Finance· 3 days agoRapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro,...